Disarm Therapeutics' Series A Round

Disarm Therapeutics raised a round of funding on September 19, 2017.

Disarm Therapeutics is developing therapeutics to treat patients with neurological diseases by preventing axonal degeneration.…

Articles about Disarm Therapeutics' Series A Round: